Larotrectinib Capsules and Panatuss DXP
Determining the interaction of Larotrectinib Capsules and Panatuss DXP and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
Generic Name: dexbrompheniramine / dextromethorphan / phenylephrine
Brand name: Alahist CF, G-P-Tuss DXP, Panatuss DXP, Supress A Pediatric, Alahist DM, Bionatuss, Supress A, Tussall, Tussall-ER, Dexall, Y-Cof DM, Panatuss Pediatric DXP
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Larotrectinib Capsules-Panatuss PED
- Larotrectinib Capsules-Panatuss PED Drops
- Larotrectinib Capsules-Pancof HC
- Larotrectinib Capsules-Pancof XP
- Larotrectinib Capsules-Pancreatin
- Larotrectinib Capsules-Pancreatin 4X
- Panatuss DXP-Larotrectinib Oral Solution
- Panatuss DXP-Larotrectinib Sulfate
- Panatuss DXP-Lartruvo
- Panatuss DXP-Larynex
- Panatuss DXP-Laryng-O-Jet
- Panatuss DXP-Laryngesic